Related Experiment Video
Updated: Feb 10, 2026

Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
[Identifying the Importance of MT-3 Expression for Neuroblastoma Cells]
Background:
Resistance of cancer cells to cytostatics is caused by a number of mechanisms that are often combined. These include reduced cell entry or increased efflux, increased DNA repair, defects of, apoptotic pathways, increased cytostatic degradation as well as elevated levels of intracellular thiols of glutathione and metallothioneins (MT). It has been reported that high concentrations of thiol groups in the cytoplasm bind platinum alkylation derivatives and chemorezistence is due to the transfer of platinum from the cytostatic to MT, which inactivates them. Because we have shown an increase in MT levels in resistant neuroblastoma (NB) lines, but not in sensitive lines after incubation with platinum cytostatics, we have considered MT-3 for NB cells in our previous studies.
Method:
SiMa NB cell lines transfected with vector containing human MT-3 and GFP or GFP only (control). Expression Microarray Human Cancer 3711 ElectraSense medium density 4 × 2k array slides with 1,609 DNA probes (Custom Array, Bothell, WA, USA), MT-3 expression and most expressed genes validated by real-time polymerase chain reaction. Sensitivity to CDDP (cisplatin) - MTT assay, clonogenicity test, Western blott caspase cleavage and free oxygen radicals fluorescence microscopy after CellROX Deep Red Reagent staining. Levels of MT-3 mRNA in 23 samples of high-risk NB, normal human cortex and bovine adrenal glands were investigated by reverse transcription polymerase chain reaction.
Results:
Expression microarray showed downregulation 3 and overexpression of 19 genes in MT-3 transfected NB cells. Using gene ontology, over-expressed genes have been shown to drive senescence-induced oncogenes (CDKN2B and ANAPC5), and the genes of glutathione S-transferase M3, caspase 4 and DNAJB6 (chaperone neuronal proteins) were also expressed. We have demonstrated a reduced sensitivity of MT-3 transfected cells to CDDP (24h IC50 of 7.48 ± 0.97 and 19.81 ± 1.2 μg/ml), a higher number of colonies after incubation with CDDP, reduced caspase 3 after incubation with CDDP and lower free oxygen radicals after induction of CDDP. High-grade NB cells expressed MT-3 significantly more than non-tumoral adrenal cells but failed to show a clear relationship to disease course.
Conclusion:
We have demonstrated the relationship between MT-3 and senescence-induced oncogene genes and some other genes relevant to cell fate (glutathione S-transferase M3, caspase 4 and DNAJB6) and a significant proportion of MT-3 on CDDP resistance. High levels of MT-3 in high-risk NB could be one of the causes of frequent relapses in this tumor.Key words: neuroblastoma - metallothionein 3 - chemoresistance The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study. The Editorial Board declares that the manuscript met the ICMJE recommendation for biomedical papers.This work was supported by AZV CR grant 15- 28334A. Submitted: 17. 2. 2018Accepted: 16. 4. 2018.
Insights
Metallothionein-3 (MT-3) overexpression in neuroblastoma cells reduces sensitivity to cisplatin chemotherapy. High MT-3 levels in high-risk neuroblastoma may contribute to treatment relapse.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer cells develop resistance to chemotherapy through various mechanisms, including altered drug transport and enhanced DNA repair.
- Elevated levels of intracellular thiols, such as glutathione and metallothioneins (MT), can inactivate chemotherapy drugs like platinum derivatives.
- Metallothionein-3 (MT-3) has been investigated for its role in neuroblastoma (NB) chemoresistance.
Purpose of the Study:
- To investigate the role of Metallothionein-3 (MT-3) in neuroblastoma (NB) cells and their sensitivity to cisplatin (CDDP).
- To identify genes regulated by MT-3 in NB cells and their potential involvement in chemoresistance.
Main Methods:
- Neuroblastoma (NB) cell lines were transfected with vectors expressing human MT-3 and GFP, or GFP alone as a control.
- Gene expression profiling was performed using microarrays, with key findings validated by real-time polymerase chain reaction.
- Chemotherapy sensitivity to cisplatin (CDDP) was assessed using MTT assays, clonogenicity tests, and analysis of caspase cleavage and reactive oxygen species.
Main Results:
- MT-3 transfection led to the overexpression of genes involved in senescence (e.g., CDKN2B, ANAPC5) and other functional pathways (glutathione S-transferase M3, caspase 4, DNAJB6).
- MT-3 transfected NB cells exhibited reduced sensitivity to CDDP, increased colony formation post-treatment, decreased caspase 3 activation, and lower levels of reactive oxygen species.
- High-risk NB samples showed significantly higher MT-3 expression compared to normal adrenal cells, but a direct correlation with disease progression was not established.
Conclusions:
- MT-3 expression is linked to specific oncogenes and genes regulating cell fate, influencing cisplatin resistance in neuroblastoma.
- Elevated MT-3 levels in high-risk neuroblastoma may be a contributing factor to treatment failure and tumor relapse.
Related Concept Videos
Cell Specific Gene Expression
Cell Specific Gene Expression
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Identifying Statistically Significant Differences: The F-Test

